Dashboard
Manage Tickers

MRK


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

whats-going-on-with-merck-shares-thursday
What's Going On With Merck Shares Thursday?
09/05/2024 18:42:49

Merck stock is trading higher on Thursday after the company announced it completed negotiations with the pan-Canadian Pharmaceu...

Core News & Articles
Merck Canada And The Pan-Canadian Pharmace...
09/05/2024 15:22:26

Approved indications include the treatment of adult patients with von Hippel-Lindau (VHL) disease for associated non-metastatic...

merck-announces-canadian-authorization-of-winrevair-sotatercept-as-first-activin-signaling-inhibitor-therapy-for-pulmonary-arterial-hypertension-in-adults
Merck Announces Canadian Authorization Of ...
09/04/2024 19:01:17

merck-and-eyebio-launch-phase-2b3-trial-for-diabetic-macular-edema-treatment
Merck and EyeBio Launch Phase 2b/3 Trial f...
09/04/2024 10:45:19

Merck (NYSE:MRK), known as MSD outside of the United States and Canada, and EyeBio, a wholly-owned subsidiary of Merck & Co...

mercks-death-cross-vs-gileads-golden-cross-pharma-giants-diverge-on-wall-street
Merck's Death Cross Vs. Gilead's Golden Cr...
09/03/2024 20:17:53

Merck flirts with bearish trends; Gilead is on a golden streak. Who wins? Investors should keep an eye on these diverging techn...

despite-medicare-negotiations-americans-may-still-have-to-pay-more-for-prescription-drugs
Despite Medicare Negotiations, Americans M...
09/03/2024 19:12:09

Despite Medicare's first-ever negotiated drug prices under the Inflation Reduction Act, U.S. costs remain significantly hig...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
09/03/2024 17:35:17

mrk---analyzing-merck--cos-short-interest
(MRK) - Analyzing Merck & Co's Short Interest
09/03/2024 14:15:24

the-european-commission-has-approved-mercks-keytruda-pembrolizumab-in-combination-with-padcev-enfortumab-vedotin-ejfv-for-the-first-line-treatment-of-unresectable-or-metastatic-urothelial-carcinoma-in-adults
The European Commission Has Approved Merck...
09/03/2024 10:49:52

behind-the-scenes-of-merck--cos-latest-options-trends
Behind the Scenes of Merck & Co's Latest O...
08/30/2024 20:33:19

Core News & Articles
Moderna And BioNTech Bet On Personalized C...
08/29/2024 16:01:34

BioNTech and Moderna are advancing personalized cancer vaccines using mRNA technology. Despite promising early results, these i...

cantor-fitzgerald-reiterates-overweight-on-merck--co-maintains-155-price-target
Cantor Fitzgerald Reiterates Overweight on...
08/29/2024 15:29:12

Cantor Fitzgerald analyst Louise Chen reiterates Merck & Co (NYSE:MRK) with a Overweight and maintains $155 price target.

merck-pulls-plug-on-two-keytruda-late-stage-studies-on-underwhelming-data
Merck Pulls Plug On Two Keytruda Late-Stag...
08/29/2024 14:35:31

Merck discontinues two Phase 3 trials, KEYNOTE-867 and KEYNOTE-630, for Keytruda in lung cancer and cutaneous squamous cell car...

merck-to-discontinue-phase-3-keynote-867-trial-of-keytruda-plus-stereotactic-body-radiotherapy-for-patients-with-stage-i-or-ii-non-small-cell-lung-cancer-and-phase-3-keynote-630-trial-of-keytruda-as-adjuvant-treatment-of-patients-with-high-risk-locally-advanced-cutaneous-squamous-cell-carcinoma-following-surgery-and-radiation
Merck To Discontinue Phase 3 Keynote-867 T...
08/29/2024 10:34:09

. This decision is based on the recommendation of an independent Data Monitoring Committee (DMC), which reviewed data from a pl...

comparing-merck-amp-co-with-industry-competitors-in-pharmaceuticals-industry
Comparing Merck & Co With Industry Com...
08/28/2024 15:00:55

merck-has-initiated-shorespan-007-phase-3-trial-of-bomedemstat-for-essential-thrombocythemia-who-have-previously-not-received-cytoreductive-therapy
Merck Has Initiated Shorespan-007 Phase 3 ...
08/27/2024 10:49:46

merck--cos-options-a-look-at-what-the-big-money-is-thinking
Merck & Co's Options: A Look at What the B...
08/26/2024 19:45:40

the-european-commission-approved-mercks-winrevair-sotatercept-in-combination-with-other-pulmonary-arterial-hypertension-pah-therapies-for-pah-in-adult-patients-with-world-health-organization-functional-class-ii-to-iii-to-improve-exercise-capacity
The European Commission Approved Merck's W...
08/26/2024 10:49:56

cancer-medicines-from-merck-bristol-myers-and-beigene-in-question-as-fda-committee-to-discuss-limiting-pd-1-drugs-for-stomach-cancer
Cancer Medicines From Merck, Bristol Myers...
08/23/2024 18:10:48

The FDA's Oncologic Drugs Advisory Committee will meet on September 26 to reevaluate the approvals of checkpoint inhibitors...

mercks-ebola-vaccine-showed-84-effectiveness-during-large-outbreak-in-africa
Merck's Ebola Vaccine Showed 84% Effective...
08/22/2024 13:40:29

Merck's rVSV-ZEBOV vaccine, the only WHO-prequalified vaccine for Ebola outbreaks caused by the Zaire ebolavirus, is FDA-ap...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION